StockData
IM Cannabis Corp. logo

IM Cannabis Corp. (IMCC) stock

IMCCNasdaqMedicinal Chemicals & Botanical ProductsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 20-F on Mar 30, 2026Score 4/30
$0.55−0.02 (-3.83%)

Close on Nov 12, 2026Market cap $3.26MP/E –Yield –

IM Cannabis gross margin

Gross margin is gross profit as a percentage of revenue.

For fiscal 2025 it was 17.7%, against 15.6% the year before. The highest annual figure on record is 65.9% in fiscal 2020.

Annual gross margin

PeriodPeriod endValueChange (pts)
FY2025Dec 31, 202517.7%+2.1
FY2024Dec 31, 202415.6%−4.5
FY2023Dec 31, 202320.2%+3.3
FY2022Dec 31, 202216.9%−1.7
FY2021Dec 31, 202118.6%−47.3
FY2020Dec 31, 202065.9%+22.6
FY2019Dec 31, 201943.3%–

Quarterly gross margin

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange (pts)
Q2 FY2026Jun 30, 202619.8%+2.5
Q2 FY2025Jun 30, 202527.0%+32.1
Q2 FY2024Jun 30, 20245.7%–
Q2 FY2023Jun 30, 202326.2%–
Q2 FY2022Jun 30, 202217.3%–
Q2 FY2021Jun 30, 2021-5.1%–

More IM Cannabis figures

See a number that looks wrong?